UCB Logo

UCB | UCB - Profile, Filings, Stock Info & Investor Relations Data

UCB | UCB
Filings & Investor Relations Data
Login to Watchlist

Create a free account or log in.

Country
Belgium
Founded
1928

About UCB

A global biopharma company, inspired by the needs of people living with severe diseases.

At UCB, we are consistently delivering on our commitment to improve the lives of people living with severe neurological and immunological conditions. And thanks to our focused, innovative and trusted solutions, our business is strong.

Our people have lived our purpose each day since 1928, making critical investments in biopharmaceutical research and leading innovations that strive to achieve a meaningful impact on the lives of those we serve.

UCB’s ambition is to transform the lives of people living with severe diseases, allowing them to live the best life that they can – as free as possible from the challenges and uncertainty of disease. That commitment comes to life in our research and development activities across neurology, immunology and other areas where our expertise, innovation and ambition align with unmet needs.

Employees

8,600

Market Presence

Worldwide

Headquarters

ALLÉE DE LA RECHERCHE 60
1070, ANDERLECHT
Belgium

Company Video

Video thumbnail
Click to load video from YouTube

UCB (UCB)
Key Financial Data

AI-Powered Financial Insights Coming Soon

We are currently processing the filings for this company to provide automated financial statement analysis, key ratios, and risk summaries. Please check back later!

Unlock Full Company Insights & AI Chat

Create a free account or log in to add companies to your watchlist, access more data, and chat directly with filings using our AI assistant (as shown!).

UCB (UCB)
Filings & Annual Reports
Chat with AI, summarize, and extract data from processed filings! Look for the 'View & AI' button.

Quick Filters:

Advanced Filters

View all types
Filing Information Actions

Insider Trading Activity

Caeymaex Emmanuel (Executive member)
Sell EUR 389,420.15 EUR 149.95 28.04.25
Peacock Jonathan (Board)
Buy EUR 93,247.90 EUR 138.35 22.04.25
Lund- Jürgensen Kirsten (Executive member)
Buy EUR 0.00 EUR 0.00 01.04.25
Caeymaex Emmanuel (Executive member)
Sell EUR 1,362,568.51 EUR 194.65 04.03.25
Caeymaex Emmanuel (Executive member)
Buy EUR 532,630.00 EUR 76.09 04.03.25
Caeymaex Emmanuel (Executive member)
Sell EUR 769,226.28 EUR 187.62 03.03.25
Caeymaex Emmanuel (Executive member)
Sell EUR 522,643.25 EUR 185.20 03.03.25
Caeymaex Emmanuel (Executive member)
Buy EUR 271,338.00 EUR 66.18 03.03.25
Caeymaex Emmanuel (Executive member)
Buy EUR 198,273.72 EUR 70.26 03.03.25
Caeymaex Emmanuel (Executive member)
Sell EUR 1,260,465.07 EUR 180.07 28.02.25

UCB (UCB)
Stock & Investor Information

ISINs

Showing 5 of 6
BE0002730118
BE0002784651
BE0002976570
BE0003739530
BE0390119825

LEI

2138008J191VLSGY5A09

Stock Exchange Listings

Euronext Brussels

Stock Index Memberships

BEL20 STOXX Europe 600

Primary Stock Exchange Listing

View UCB on main exchange

Industry Classification